超过5%股东持股披露
Abivax(ABVX)04-20 07:15
$Abivax(ABVX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-103197 Act: 34 Size: 74 KB 网页链接
简介:Abivax Sa是一家于2013年12月4日根据法国法律注册成立。该公司是一家临床阶段的生物技术公司,专注于开发利用人体自然调节机制来调节慢性炎症性疾病患者免疫反应的疗法。该公司目前正在3期临床试验中评估主要候选药物奥贝法兹莫德,用于治疗成人中度至重度活动性溃疡性结肠炎。
今开:13.535 | 昨收:13.5 |
最高:13.535 | 最低:13.03 |
涨停价: | 跌停价: |
总市值:822333842 |
Abivax(ABVX)04-20 07:15
$Abivax(ABVX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-103197 Act: 34 Size: 74 KB 网页链接
Abivax(ABVX)05-08 04:35
$Abivax(ABVX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-002617 Act: 34 Size: 13 KB 网页链接
Abivax(ABVX)06-05 04:35
$Abivax(ABVX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-154293 Act: 34 Size: 97 KB 网页链接
SeekingBiotech05-07 12:03
mi-124炎症机制的一类长度约为18~24个核苷酸的非编码小RNA, IBD
$Abivax(ABVX)$
Abivax(ABVX)04-06 04:15
$Abivax(ABVX)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001956827-24-000007 Act: 34 Size: 40 MB 网页链接
SeekingBiotech05-07 12:03
mi-124炎症机制的一类长度约为18~24个核苷酸的非编码小RNA, IBD
$Abivax(ABVX)$查看全文
产业链观察2023-10-20 22:14
#药闻简讯# Abivax $Abivax(ABVX)$ 宣布在纳斯达克全球市场首次公开发行定价查看全文
F1watch2023-10-16 23:40
F-1/A - Abivax S.A. (0001956827) (Filer) Filed: 2023-10-16 AccNo: 0001193125-23-256667 Size: 7 MB 网页链接查看全文
$Abivax(ABVX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-154293 Act: 34 Size: 97 KB 网页链接
$Abivax(ABVX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-002617 Act: 34 Size: 13 KB 网页链接
$Abivax(ABVX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-103197 Act: 34 Size: 74 KB 网页链接
$Abivax(ABVX)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001956827-24-000007 Act: 34 Size: 40 MB 网页链接
$Abivax(ABVX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-001756 Act: 34 Size: 50 KB 网页链接
$Abivax(ABVX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-024198 Act: 34 Size: 175 KB 网页链接
$Abivax(ABVX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-000531 Act: 34 Size: 15 KB 网页链接
$Abivax(ABVX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-000324 Act: 34 Size: 24 KB 网页链接
$Abivax(ABVX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-120756 Act: 34 Size: 185 KB 网页链接
$Abivax(ABVX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-23-003538 Act: 34 Size: 102 KB 网页链接